D-erythro-Imidazoleglycerol Phosphate Monohydrate (~90%)

Catalog number TRC-I350000-1MG

Price for TRC-I350000-1MG

Size / count 1 mg

Specifications

Catalog number: TRC-I350000-1MG
Size / count: 1 mg
Dry ice: No
Hazardous: No
Discontinued: No
CAS Number: 210241-69-3
Hazard Statement: Causes skin irritation
Smiles: O.O[C@H](COP(=O)(O)O)[C@@H](O)C1C=NC=N1
Molecular Formula: C6 H11 N2 O6 P . H2 O
Molecular Weight: 256.15
InChI: InChI=1S/C6H11N2O6P.H2O/c9-5(2-14-15(11,12)13)6(10)4-1-7-3-8-4;/h1,3-6,9-10H,2H2,(H2,11,12,13);1H2/t4?,5-,6+;/m1./s1
Additionnal Information: IUPAC name: [(2R,3S)-2,3-dihydroxy-3-(4H-imidazol-4-yl)propyl] dihydrogen phosphate;hydrate
Shipping Conditions: Room Temperature
Storage Conditions: -20°C

Frequently Asked Questions

What is the catalog number for D-erythro-Imidazoleglycerol Phosphate Monohydrate (~90%)?

The catalog number for D-erythro-Imidazoleglycerol Phosphate Monohydrate (~90%) is TRC-I350000-1MG.

What sizes are available for D-erythro-Imidazoleglycerol Phosphate Monohydrate (~90%)?

D-erythro-Imidazoleglycerol Phosphate Monohydrate (~90%) is available in the following size(s): 1 mg.

Is D-erythro-Imidazoleglycerol Phosphate Monohydrate (~90%) in stock?

D-erythro-Imidazoleglycerol Phosphate Monohydrate (~90%) is currently made to order / not held in immediate stock. Contact us for lead time.

Is there an additional fee for hazardous or dry ice shipping of this product?

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

How many freeze-thaw cycles can this product tolerate?

We recommend aliquoting the product upon receipt to avoid repeated freeze-thaw cycles, which can reduce activity and stability. This is your responsibility once the product has been delivered.

Is antigen retrieval required for IHC with this antibody?

Recommended antigen retrieval methods, where applicable, are listed on the datasheet under the IHC protocol section.